Louis Libbrecht

ORCID: 0000-0002-9453-3355 · 2 papers in corpus
case-report 2012
Virchows Archiv : an international journal of pathology ·doi:10.1007/s00428-012-1264-5
observational 2009
BMC medical genomics ·doi:10.1186/1755-8794-2-69

BACKGROUND: Microarray technology has allowed to molecularly characterize many different cancer sites. This technology has the potential to individualize therapy and to discover new drug targets. However, due to technological differences an…